LungQ Software
Overview
Thirona’s LungQ® software offers advanced, AI-powered analysis of thoracic CT scans, providing comprehensive quantitative insights for the detection, evaluation, and treatment planning of various lung diseases. Leveraging deep learning models, LungQ® performs high-fidelity segmentation and quantification of anatomical structures within the lungs, including lobes, segments, subsegments, airways, blood vessels, and fissures.
The software delivers reproducible CT values for pulmonary tissue, which is crucial for objective support in diagnosis, patient selection for treatment, and longitudinal monitoring of disease progression and treatment efficacy. LungQ® analyses extend to detailed airway morphology (identifying bronchial wall thickness, dilatation, narrowing, and mucus impaction), vascular morphology (assessing pulmonary arterial and venous volume changes), and parenchymal analysis (characterizing texture patterns and estimating chronic perfusion defects, known as PXT).
Recent versions, such as LungQ® 4, have expanded capabilities to include enhanced peripheral airway segmentation, estimation of chronic perfusion defects from CT, and post-treatment detection of endobronchial implants. This technology is designed to support physicians in making more precise diagnoses, personalizing treatment strategies, guiding interventional procedures like bronchoscopy, and accelerating respiratory clinical trials.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered analysis of thoracic CT scans
- Automated segmentation of pulmonary segments and subsegments
- Volumetric analysis and quantification of anatomical structures
- Airway morphology analysis (bronchial wall thickness, dilatation, narrowing, mucus impaction)
- Vascular morphology analysis (pulmonary arterial and venous volume changes)
- Fissure completeness analysis
- Parenchymal analysis (texture patterns, estimated chronic perfusion defects - PXT)
- Post-treatment detection of endobronchial implants
- Provides reproducible CT values for pulmonary tissue
- One-page report with severity scores for emphysematous lung tissue and fissure completeness
Use Cases
- Diagnosis and evaluation of lung diseases
- Treatment planning for lung interventions (e.g., lung volume reduction, bronchoscopy)
- Follow-up and longitudinal monitoring of disease progression
- Respiratory clinical trials and drug development
- Patient phenotyping and selection for personalized medicine
- Guidance for navigational bronchoscopy
What Physicians Need to Know
When using LungQ, pay close attention to the quantitative measurements provided for bronchial dilation, wall thickening, mucus plugs, and pulmonary blood volume distribution, as these can offer precise insights beyond visual assessment. Leverage the enhanced peripheral airway segmentation for more accurate planning of bronchoscopic interventions, especially for distal targets. Utilize the PXT feature for patient selection and treatment planning in lung volume reduction therapies. For longitudinal follow-up, the software's ability to track changes over time can be invaluable for assessing disease progression and treatment response. Remember that while the software provides detailed analysis, clinical correlation with patient symptoms and other diagnostic findings remains crucial for comprehensive patient care.
LungQ is designed for flexible integration into existing clinical workflows and systems, including interventional systems and research and development environments. It is available through AI marketplaces and distribution platforms, such as the Blackford Platform. Deployment is typically local on dedicated hardware. While it operates as a command-line interface, its modular design allows for adaptability across various use cases and therapeutic areas.
Details
| Category | Oncology AI, Radiology & Imaging AI |
| Pricing | Contact-for-pricing |
| Deployment | Software solution, designed for integration into clinical workflows and systems. |
| Compliance | |
| BAA Available | No AI-estimated |
| HIPAA Compliant | Unknown |
| FDA Status | Cleared AI-estimated |
| SOC 2 | No AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Pulmonology, Radiology |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2018-06-05 | K173821 510(k) | LungQ Software |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate LungQ Software
Videos
Product demos, reviews, and walkthroughs for LungQ Software.
Thirona LungQ COPD CTA
Gideon Attwell







